Literature DB >> 15944708

MicroRNA expression profiles classify human cancers.

Jun Lu1, Gad Getz, Eric A Miska, Ezequiel Alvarez-Saavedra, Justin Lamb, David Peck, Alejandro Sweet-Cordero, Benjamin L Ebert, Raymond H Mak, Adolfo A Ferrando, James R Downing, Tyler Jacks, H Robert Horvitz, Todd R Golub.   

Abstract

Recent work has revealed the existence of a class of small non-coding RNA species, known as microRNAs (miRNAs), which have critical functions across various biological processes. Here we use a new, bead-based flow cytometric miRNA expression profiling method to present a systematic expression analysis of 217 mammalian miRNAs from 334 samples, including multiple human cancers. The miRNA profiles are surprisingly informative, reflecting the developmental lineage and differentiation state of the tumours. We observe a general downregulation of miRNAs in tumours compared with normal tissues. Furthermore, we were able to successfully classify poorly differentiated tumours using miRNA expression profiles, whereas messenger RNA profiles were highly inaccurate when applied to the same samples. These findings highlight the potential of miRNA profiling in cancer diagnosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15944708     DOI: 10.1038/nature03702

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  2000 in total

Review 1.  MicroRNAs, wild-type and mutant p53: more questions than answers.

Authors:  Matthew Jones; Ashish Lal
Journal:  RNA Biol       Date:  2012-06-01       Impact factor: 4.652

2.  Transcriptional regulation of the protocadherin β cluster during Her-2 protein-induced mammary tumorigenesis results from altered N-glycan branching.

Authors:  Huabei Guo; Alison Nairn; Mitche dela Rosa; Tamas Nagy; Shaying Zhao; Kelley Moremen; Michael Pierce
Journal:  J Biol Chem       Date:  2012-06-04       Impact factor: 5.157

3.  Functional genomics of tumor suppressor miR-196b in T-cell acute lymphoblastic leukemia.

Authors:  Suman Bhatia; Deepak Kaul; Neelam Varma
Journal:  Mol Cell Biochem       Date:  2010-10-06       Impact factor: 3.396

4.  Expression of miR-149-3p inhibits proliferation, migration, and invasion of bladder cancer by targeting S100A4.

Authors:  Dengke Yang; Guang Du; An Xu; Xuetao Xi; Dong Li
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

Review 5.  MicroRNAs in mucosal inflammation.

Authors:  Viola Neudecker; Xiaoyi Yuan; Jessica L Bowser; Holger K Eltzschig
Journal:  J Mol Med (Berl)       Date:  2017-07-20       Impact factor: 4.599

6.  miR-23a promotes invasion of glioblastoma via HOXD10-regulated glial-mesenchymal transition.

Authors:  Kazuhiro Yachi; Masumi Tsuda; Shinji Kohsaka; Lei Wang; Yoshitaka Oda; Satoshi Tanikawa; Yusuke Ohba; Shinya Tanaka
Journal:  Signal Transduct Target Ther       Date:  2018-12-28

7.  Clusterin is a gene-specific target of microRNA-21 in head and neck squamous cell carcinoma.

Authors:  Wojciech Mydlarz; Mamoru Uemura; Sun Ahn; Patrick Hennessey; Steven Chang; Semra Demokan; Wenyue Sun; Chunbo Shao; Justin Bishop; Julie Krosting; Elizabeth Mambo; William Westra; Patrick Ha; David Sidransky; Joseph Califano
Journal:  Clin Cancer Res       Date:  2013-12-10       Impact factor: 12.531

8.  Differential expression of microRNA species in human uterine leiomyoma versus normal myometrium.

Authors:  Erica E Marsh; Zhihong Lin; Ping Yin; Magdy Milad; Debabrata Chakravarti; Serdar E Bulun
Journal:  Fertil Steril       Date:  2007-09-04       Impact factor: 7.329

9.  Low-level expression of microRNAs let-7d and miR-205 are prognostic markers of head and neck squamous cell carcinoma.

Authors:  Geoffrey Childs; Melissa Fazzari; Gloria Kung; Nicole Kawachi; Margaret Brandwein-Gensler; Michael McLemore; Quan Chen; Robert D Burk; Richard V Smith; Michael B Prystowsky; Thomas J Belbin; Nicolas F Schlecht
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

10.  Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile.

Authors:  Johan H Gibcus; Lu Ping Tan; Geert Harms; Rikst Nynke Schakel; Debora de Jong; Tjasso Blokzijl; Peter Möller; Sibrand Poppema; Bart-Jan Kroesen; Anke van den Berg
Journal:  Neoplasia       Date:  2009-02       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.